These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6789937)

  • 21. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial.
    Kantarjian HM; Roboz GJ; Kropf PL; Yee KWL; O'Connell CL; Tibes R; Walsh KJ; Podoltsev NA; Griffiths EA; Jabbour E; Garcia-Manero G; Rizzieri D; Stock W; Savona MR; Rosenblat TL; Berdeja JG; Ravandi F; Rock EP; Hao Y; Azab M; Issa JJ
    Lancet Oncol; 2017 Oct; 18(10):1317-1326. PubMed ID: 28844816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of CNS leukaemia in acute myeloid leukaemia in childhood.
    Kay HE
    Arch Dis Child; 1976 Jan; 51(1):73-4. PubMed ID: 1066085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in acute myelogenous leukemia.
    Gale RP
    Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy.
    Powles RL; Lister TA; Oliver RT; Russell J; Smith C; Kay HE; McElwain TJ; Fairley GH
    Br Med J; 1974 Nov; 4(5941):375-9. PubMed ID: 4529647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term survival in children with acute leukaemia and complications requiring mechanical ventilation.
    Steinbach D; Wilhelm B; Kiermaier HR; Creutzig U; Schrappe M; Zimmermann M; Debatin KM; Gruhn B; von Stackelberg A; Jürgens H; Strahm B; Reinhardt D; Möricke A
    Arch Dis Child; 2011 Nov; 96(11):1026-32. PubMed ID: 21719441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival.
    Diakiw SM; Perugini M; Kok CH; Engler GA; Cummings N; To LB; Wei AH; Lewis ID; Brown AL; D'Andrea RJ
    Br J Haematol; 2013 Jun; 161(6):884-8. PubMed ID: 23521344
    [No Abstract]   [Full Text] [Related]  

  • 27. Advances in the management of adult acute myelogenous leukaemia.
    Whittaker JA
    Br Med J; 1980 Oct; 281(6246):960-4. PubMed ID: 7000284
    [No Abstract]   [Full Text] [Related]  

  • 28. Outcome in elderly acute myeloid leukaemia.
    Osman H; Murray M; Egan E; O'Dwyer M
    Ir Med J; 2008; 101(10):307-10. PubMed ID: 19205141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis in acute myeloid leukaemia.
    Catovsky D
    Br Med J (Clin Res Ed); 1981 Jun; 282(6282):2134. PubMed ID: 6788235
    [No Abstract]   [Full Text] [Related]  

  • 30. Prognosis of acute myelogenous leukemia.
    Lahuerta-Palacios JJ; Larregla-Garraus S; Fernández-Debora F; Ruiz de Adana R
    Ann Intern Med; 1982 Jul; 97(1):140. PubMed ID: 6953778
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT).
    Frassoni F; Labopin M; Gluckman E; Prentice HG; Gahrton G; Mandelli F; Carella M; Herve P; Gratwohl A; Goldman J
    Leukemia; 1994 Jun; 8(6):924-8. PubMed ID: 8207985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of acute myeloid leukaemia.
    Chopra R
    Br J Hosp Med; 1992 Oct 7-20; 48(7):363-75. PubMed ID: 1393232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
    Röllig C; Serve H; Hüttmann A; Noppeney R; Müller-Tidow C; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Kiani A; Frickhofen N; Kullmer J; Kaiser U; Link H; Geer T; Reichle A; Junghanß C; Repp R; Heits F; Dürk H; Hase J; Klut IM; Illmer T; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Schetelig J; Kramer M; Berdel WE; Ehninger G;
    Lancet Oncol; 2015 Dec; 16(16):1691-9. PubMed ID: 26549589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [General strategy for acute myelogenous leukaemia therapy (author's transl)].
    Fernández-Rañada J; Escudero A; Vázquez L; Gómez-Reino F; Fernández-Villalta MJ; Fernández de Pivel D; Merino JL; Olmeda F
    Sangre (Barc); 1981; 26(5B):855-66. PubMed ID: 7034245
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone marrow transplantation for leukaemia in Europe.
    Gratwohl A; Hermans J; Lyklema A; Zwaan FE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):353-60. PubMed ID: 2480274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice.
    Lee EM; Yee D; Busfield SJ; McManus JF; Cummings N; Vairo G; Wei A; Ramshaw HS; Powell JA; Lopez AF; Lewis ID; McCall MN; Lock RB
    Haematologica; 2015 Jul; 100(7):914-26. PubMed ID: 26130514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.
    Labar B; Masszi T; Morabito F; Mistrik M; Holowiecki J; Bogdanić V; Nemet D; Mrsić M; Krieger O; Lutz D
    Bone Marrow Transplant; 1996 Jun; 17(6):1009-12. PubMed ID: 8807107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
    Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
    Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransfusion hepatitis in acute myelogenous leukemia.
    Novak RW
    JAMA; 1981 Jul; 246(3):215-6. PubMed ID: 6941034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.